Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval

SHANGHAI, Jan. 2, 2024 -- (Healthcare Sales & Marketing Network) -- Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), recently announced that it has successfully obtained ... Devices, Regulatory, FDA, Reimbursement Pulnovo Medical, PADN Catheter, pulmonary arterial hypertension
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news